Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Szubert

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Infection|August 10, 2019
Predictors of recurrence, early treatment failure and death from Staphylococcus aureus bacteraemia: Observational analyses within the ARREST trialAlexander Szubert, Sarah Lou Bailey, Graham S Cooke, et al.
Blood|August 27, 2013
The impact of response on bone-directed therapy in patients with multiple myelomaAlessandra Larocca, J Anthony Child, Gordon Cook, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 16, 2025
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIVAnne E M Kamphuis, Hylke Waalewijn, Roeland E Wasmann, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2025
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIVLufina Tsirizani, Hylke Waalewijn, Alexander Szubert, et al.
The Journal of Antimicrobial Chemotherapy|September 20, 2024
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIVLufina Tsirizani, Shaghayegh Mohsenian Naghani, Hylke Waalewijn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2024
Clinical Subphenotypes of Staphylococcus aureus BacteremiaMaaike C Swets, Zsuzsa Bakk, Annette C Westgeest, et al.
Lancet (London, England)|December 19, 2017
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trialGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Health Technology Assessment (Winchester, England)|November 2, 2018
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Infection|August 10, 2019
Predictors of recurrence, early treatment failure and death from Staphylococcus aureus bacteraemia: Observational analyses within the ARREST trialAlexander Szubert, Sarah Lou Bailey, Graham S Cooke, et al.
Blood|August 27, 2013
The impact of response on bone-directed therapy in patients with multiple myelomaAlessandra Larocca, J Anthony Child, Gordon Cook, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 16, 2025
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIVAnne E M Kamphuis, Hylke Waalewijn, Roeland E Wasmann, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2025
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIVLufina Tsirizani, Hylke Waalewijn, Alexander Szubert, et al.
The Journal of Antimicrobial Chemotherapy|September 20, 2024
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIVLufina Tsirizani, Shaghayegh Mohsenian Naghani, Hylke Waalewijn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2024
Clinical Subphenotypes of Staphylococcus aureus BacteremiaMaaike C Swets, Zsuzsa Bakk, Annette C Westgeest, et al.
Lancet (London, England)|December 19, 2017
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trialGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Health Technology Assessment (Winchester, England)|November 2, 2018
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Pageof 1